Results 81 to 90 of about 3,709 (164)

Monitoring blast wave evolution and propagation using coupled visual recording and pressure measurements. [PDF]

Sci Rep
Sławski S, Polis M, Krzystała E, Szydło K, Duda S, Stolarczyk A, Jarosz T.   +6 more
europepmc   +1 more source

Navigating hepatotoxicity of antibody-drug conjugates: from mechanistic insights to clinical and postmarketing evidence. [PDF]

Front Pharmacol
Dong Y, Zhi Y, Li X, Ma M, Ye M, Huang S, Tang J, Zhong W, Lei X, Mao Y.   +9 more
europepmc   +1 more source

A Comparative Study of Porcine and Ovine Derived Defibrotide: Coagulation Profiles, Molecular Characteristics, and DNA Content. [PDF]

Clin Appl Thromb Hemost
Abourahma H, Kempaiah P, Farooqui A, Krupa E, Iqbal O, Fareed J, Yao Y.   +6 more
europepmc   +1 more source

Where do immunotherapies stand in management of acute leukemia in adults? [PDF]

Hematology Am Soc Hematol Educ Program
Boissel N.
europepmc   +1 more source

Late-Onset Veno-Occlusive Disease (VOD) Post Haploidentical Transplant: A Diagnostic Challenge Requiring Liver Biopsy- A Case Report. [PDF]

Mediterr J Hematol Infect Dis
Trehan M, Sharma H, Sengupta A, Burli A, Kumar P, Mahapatra M.   +5 more
europepmc   +1 more source

Land use-induced soil carbon loss in the dry tropics nearly offsets gains in northern lands. [PDF]

Nat Commun
Wang H, Ciais P, Yang H, Smith P, Grassi G, Schwingshackl C, Panagos P, Bar-On Y, Sitch S, Chevallier F, Palmer PI, Li X, Hong S, Chang J, Albergel C, Fan L, Wang K, Liu L, Frappart F, Wigneron JP.   +19 more
europepmc   +1 more source

Syphilitic Uveitis: Clinical Features, Treatment, and Outcome. [PDF]

Am J Case Rep
Valcheva KP.
europepmc   +1 more source

Synergistic Driver-Laser/Modulator Co-Design with Versatile Output Stage: A Unified Optical Transmitter EIC Design Approach. [PDF]

Micromachines (Basel)
Yang R, Li C, Xia Y, Yang Y, Geng L, Li D.   +5 more
europepmc   +1 more source

Immune-related toxicity profile after haematopoietic stem cell transplantation in patients with B-ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab. [PDF]

Br J Haematol
Okeleji O, McCall D, Cuglievan B, Gibson A, Petropoulos D, Tewari P, Connors J, Sheikh IN.   +7 more
europepmc   +1 more source

Real-world treatment outcome and toxicity analysis of inotuzumab ozogamicin in adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: multicenter prospective observational study. [PDF]

Ther Adv Hematol
Yoon JH, Park HS, Song IC, Jung SH, Lee S.   +4 more
europepmc   +1 more source